Biophysical chemistry · 2026
Crystal structures, DNA interaction of natural anthraquinone compounds and dual apoptotic mechanisms in oral cancer CAL-27 cells.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Long Xing, Chen Lin, Zhong Wen, Liu Di, Li Yanping, Chen Shaofeng, Lin Shijie, Yang Zengyan, Tian Wei
Аннотация
Natural anthraquinone compounds have demonstrated significant potential as anticancer agents due to their diverse biological activities. Herein, we determined the crystal structures of a series of natural anthraquinone compounds (chrysophanol, emodin, aloe emodin, and rhein) for the first time, and observed that these compounds form one-dimensional supramolecular chain structures and two-dimensional supramolecular structures through C-H…O, C-H…O or C-H…S hydrogen bonding interactions. Besides, we evaluated the anti-proliferative activity of these natural anthraquinone compounds on oral cancer CLA-27 cells. Among them, rhein exhibited significant anti-proliferative activity, superior to carboplatin, with an IC₅₀ value of 72.4 ± 3.7 μM against CAL-27 cells. The strong intercalation effect of rhein with DNA was verified by EB-DNA fluorescence spectroscopy, and the Stern-Volmer quenching constant (Kₛᵥ) for the rhein-DNA interaction was determined to be 5.67 × 104 L·mol-1. The flow cytometry results indicated that that rhein induced apoptosis in a dose-dependent manner, with apoptosis percentages of 15.4 ± 0.7%, 25.2 ± 2.3%, and 34.6 ± 1.8% at 25, 50, and 100 μM, respectively. Moreover, rhein not only activates the mitochondrial-mediated apoptosis signaling pathway (Bax/Bcl-2/cytochrome C/cleaved caspase-3) but also highly activates the expression level of the DNA damage protein γ-H2AX. This study provides new insights into the development of natural anthraquinone compounds as promising candidates for oral cancer therapies.